EAM Global Investors’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-28,976
| Closed | -$5.27M | – | 145 |
|
|
2024
Q3 | $5.27M | Buy |
28,976
+133
| +0.5% | +$24.2K | 1.06% | 35 |
|
|
2024
Q2 | $5.3M | Buy |
28,843
+1
| +0% | +$184 | 1.19% | 30 |
|
|
2024
Q1 | $5.13M | Buy |
+28,842
| New | +$5.13M | 1.19% | 30 |
|
|
2023
Q4 | – | Sell |
-29,517
| Closed | -$3.42M | – | 131 |
|
|
2023
Q3 | $3.42M | Sell |
29,517
-5,653
| -16% | -$656K | 0.93% | 68 |
|
|
2023
Q2 | $4.13M | Buy |
+35,170
| New | +$4.13M | 1.21% | 43 |
|
|
2023
Q1 | – | Sell |
-21,605
| Closed | -$1.71M | – | 143 |
|
|
2022
Q4 | $1.71M | Hold |
21,605
| – | – | 0.44% | 115 |
|
|
2022
Q3 | $1.51M | Hold |
21,605
| – | – | 0.4% | 133 |
|
|
2022
Q2 | $1.42M | Sell |
21,605
-354
| -2% | -$23.3K | 0.35% | 146 |
|
|
2022
Q1 | $1.46M | Hold |
21,959
| – | – | 0.27% | 184 |
|
|
2021
Q4 | $1.54M | Buy |
+21,959
| New | +$1.54M | 0.27% | 180 |
|
|
2020
Q2 | – | Sell |
-30,065
| Closed | -$1.3M | – | 135 |
|
|
2020
Q1 | $1.3M | Sell |
30,065
-5
| -0% | -$216 | 0.76% | 67 |
|
|
2019
Q4 | $1.67M | Sell |
30,070
-11,259
| -27% | -$623K | 0.67% | 84 |
|
|
2019
Q3 | $1.44M | Buy |
41,329
+8,192
| +25% | +$284K | 0.7% | 78 |
|
|
2019
Q2 | $1.33M | Buy |
+33,137
| New | +$1.33M | 0.57% | 104 |
|